You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 8, August 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Genetics of Head & Neck Disease
 •Neoplasms of Head & Neck
 •Pathology of Head & Neck
 •Prognosis/ Outcomes
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Prognostic Significance of p21WAF1/CIP1 Expression in Tongue Squamous Cell Carcinomas

Xin Xie, MD, PhD; Ole Petter F. Clausen, MD, PhD; Morten Boysen, MD, PhD

Arch Otolaryngol Head Neck Surg. 2002;128:897-902.

Objective  To investigate the prognostic significance of p21WAF1/CIP1 expression and its relationship with p53 accumulation and other apoptotic markers such as Bax, Bcl-2, and apoptotic index in relation to disease-specific survival in oral tongue squamous cell carcinoma (SCC).

Design  A 10-year retrospective clinical study. Information about clinical findings, treatment, and follow-up has been recorded prospectively.

Patients and Methods  Diagnostic, formalin-fixed, paraffin-embedded sections taken from 80 randomly selected patients before treatment for T1 to T4 oral tongue SCC were stained immunohistochemically with p21WAF1/CIP1. The percentages of positive nuclei that stained positive for tumor were determined.

Main Outcome Measures  The significance of prognostic parameters was tested by log-rank and Kaplan-Meier methods for the univariate analysis. The Cox proportional hazards regression model was used for multivariate analysis.

Results  Expression of p21WAF1/CIP1 correlated inversely with T classification and clinical stage (P = .02 and P = .006, respectively) but not with N classification, tumor differentiation, or apoptosis-related variables such as p53 accumulation, apoptotic index, and Bax and Bcl-2 expression. Patients with tumors expressing high p21WAF1/CIP1 values had increased disease-specific survival time (P = .03). The correlation between p21WAF1/CIP1 expression and disease-specific survival was even more significant when restricted to p53-negative tumors (P = .002). A 2-parameter combination between p21WAF1/CIP1 expression and Bax expression or p21WAF1/CIP1 expression and p53 accumulation, respectively, revealed an enhanced prognostic potential (P<.001) when compared with single parameters.

Conclusion  The expression of p21WAF1/CIP1, particularly in combination with p53 accumulation or Bax expression, has prognostic value in oral tongue SCC.


From the Department of Otolaryngology (Drs Xie and Boysen) and the Institute for Pathology (Drs Xie and Clausen), The National Hospital, University of Oslo, Oslo, Norway.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pilot Study of Neoadjuvant Treatment with Erlotinib in Nonmetastatic Head and Neck Squamous Cell Carcinoma
Thomas et al.
Clin. Cancer Res. 2007;13:7086-7092.
ABSTRACT | FULL TEXT  

Expression of p21WAF in Salivary Gland Mucoepidermoid Carcinoma and Its Relation to Histologic Grade
Etemad-Moghadam et al.
INT J SURG PATHOL 2007;15:6-13.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.